Yvonne Linney

Yvonne Linney has over 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products. She is currently Principal at Linney Bioconsulting as well as serving as a Bionano Genomics, Inc. board member. As a former executive leader at venture-funded Strateos (previously Transcriptic) and Artificial Inc., Dr. Linney brings deep insight from her knowledge of early-stage startups. In addition, she has years of leadership and commercialization experience at companies including Agilent Technologies, Siemens Healthcare (previously Bayer Diagnostics), Caliper Life Sciences, and GE Healthcare (previously Amersham International and Pharmacia Biotech). Dr. Linney earned her Ph.D. in Genetics from the University of Leicester.